These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 27881875)

  • 1. Loss of p300 accelerates MDS-associated leukemogenesis.
    Cheng G; Liu F; Asai T; Lai F; Man N; Xu H; Chen S; Greenblatt S; Hamard PJ; Ando K; Chen X; Wang L; Martinez C; Tadi M; Wang L; Xu M; Yang FC; Shiekhattar R; Nimer SD
    Leukemia; 2017 Jun; 31(6):1382-1390. PubMed ID: 27881875
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SETD2 deficiency accelerates MDS-associated leukemogenesis via S100a9 in NHD13 mice and predicts poor prognosis in MDS.
    Chen BY; Song J; Hu CL; Chen SB; Zhang Q; Xu CH; Wu JC; Hou D; Sun M; Zhang YL; Liu N; Yu PC; Liu P; Zong LJ; Zhang JY; Dai RF; Lan F; Huang QH; Zhang SJ; Nimer SD; Chen Z; Chen SJ; Sun XJ; Wang L
    Blood; 2020 Jun; 135(25):2271-2285. PubMed ID: 32202636
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting of the bone marrow microenvironment improves outcome in a murine model of myelodysplastic syndrome.
    Balderman SR; Li AJ; Hoffman CM; Frisch BJ; Goodman AN; LaMere MW; Georger MA; Evans AG; Liesveld JL; Becker MW; Calvi LM
    Blood; 2016 Feb; 127(5):616-25. PubMed ID: 26637787
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Depletion of cytotoxic T-cells does not protect NUP98-HOXD13 mice from myelodysplastic syndrome but reveals a modest tumor immunosurveillance effect.
    Gough SM; Chung YJ; Aplan PD
    PLoS One; 2012; 7(5):e36876. PubMed ID: 22606303
    [TBL] [Abstract][Full Text] [Related]  

  • 5. p300 suppresses the transition of myelodysplastic syndromes to acute myeloid leukemia.
    Man N; Mas G; Karl DL; Sun J; Liu F; Yang Q; Torres-Martin M; Itonaga H; Martinez C; Chen S; Xu Y; Duffort S; Hamard PJ; Chen C; Zucconi BE; Cimmino L; Yang FC; Xu M; Cole PA; Figueroa ME; Nimer SD
    JCI Insight; 2021 Oct; 6(19):. PubMed ID: 34622806
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loss of p53 accelerates the complications of myelodysplastic syndrome in a NUP98-HOXD13-driven mouse model.
    Xu H; Menendez S; Schlegelberger B; Bae N; Aplan PD; Göhring G; Deblasio TR; Nimer SD
    Blood; 2012 Oct; 120(15):3089-97. PubMed ID: 22927245
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of apoptosis by BCL2 prevents leukemic transformation of a murine myelodysplastic syndrome.
    Slape CI; Saw J; Jowett JB; Aplan PD; Strasser A; Jane SM; Curtis DJ
    Blood; 2012 Sep; 120(12):2475-83. PubMed ID: 22855610
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PUMA promotes apoptosis of hematopoietic progenitors driving leukemic progression in a mouse model of myelodysplasia.
    Guirguis AA; Slape CI; Failla LM; Saw J; Tremblay CS; Powell DR; Rossello F; Wei A; Strasser A; Curtis DJ
    Cell Death Differ; 2016 Jun; 23(6):1049-59. PubMed ID: 26742432
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification and characterization of leukemia stem cells in murine MLL-AF9 acute myeloid leukemia.
    Somervaille TC; Cleary ML
    Cancer Cell; 2006 Oct; 10(4):257-68. PubMed ID: 17045204
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting miR-126 disrupts maintenance of myelodysplastic syndrome stem and progenitor cells.
    Wang H; Sun J; Zhang B; Zhao D; Tong H; Wu H; Li X; Luo Y; Dong D; Yao Y; McDonald T; Stein AS; Al Malki MM; Pichiorri F; Carlesso N; Kuo YH; Marcucci G; Li L; Jin J
    Clin Transl Med; 2021 Oct; 11(10):e610. PubMed ID: 34709739
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Searching for leukemia stem cells--not yet the end of the road?
    Jordan CT
    Cancer Cell; 2006 Oct; 10(4):253-4. PubMed ID: 17045202
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progressive genomic instability in the Nup98-HoxD13 model of MDS correlates with loss of the PIG-A gene product.
    Byrne M; Bennett RL; Cheng X; May WS
    Neoplasia; 2014 Aug; 16(8):627-33. PubMed ID: 25220590
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TLR2/6 signaling promotes the expansion of premalignant hematopoietic stem and progenitor cells in the NUP98-HOXD13 mouse model of MDS.
    Monlish DA; Greenberg ZJ; Bhatt ST; Leonard KM; Romine MP; Dong Q; Bendesky L; Duncavage EJ; Magee JA; Schuettpelz LG
    Exp Hematol; 2020 Aug; 88():42-55. PubMed ID: 32652111
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MSI2 is required for maintaining activated myelodysplastic syndrome stem cells.
    Taggart J; Ho TC; Amin E; Xu H; Barlowe TS; Perez AR; Durham BH; Tivnan P; Okabe R; Chow A; Vu L; Park SM; Prieto C; Famulare C; Patel M; Lengner CJ; Verma A; Roboz G; Guzman M; Klimek VM; Abdel-Wahab O; Leslie C; Nimer SD; Kharas MG
    Nat Commun; 2016 Feb; 7():10739. PubMed ID: 26898884
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Leukemic transformation in mice expressing a NUP98-HOXD13 transgene is accompanied by spontaneous mutations in Nras, Kras, and Cbl.
    Slape C; Liu LY; Beachy S; Aplan PD
    Blood; 2008 Sep; 112(5):2017-9. PubMed ID: 18566322
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oxidative stress leads to increased mutation frequency in a murine model of myelodysplastic syndrome.
    Chung YJ; Robert C; Gough SM; Rassool FV; Aplan PD
    Leuk Res; 2014 Jan; 38(1):95-102. PubMed ID: 23958061
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting p300 Addiction in CBP-Deficient Cancers Causes Synthetic Lethality by Apoptotic Cell Death due to Abrogation of MYC Expression.
    Ogiwara H; Sasaki M; Mitachi T; Oike T; Higuchi S; Tominaga Y; Kohno T
    Cancer Discov; 2016 Apr; 6(4):430-45. PubMed ID: 26603525
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SIRT1 Activation Disrupts Maintenance of Myelodysplastic Syndrome Stem and Progenitor Cells by Restoring TET2 Function.
    Sun J; He X; Zhu Y; Ding Z; Dong H; Feng Y; Du J; Wang H; Wu X; Zhang L; Yu X; Lin A; McDonald T; Zhao D; Wu H; Hua WK; Zhang B; Feng L; Tohyama K; Bhatia R; Oberdoerffer P; Chung YJ; Aplan PD; Boultwood J; Pellagatti A; Khaled S; Kortylewski M; Pichiorri F; Kuo YH; Carlesso N; Marcucci G; Jin H; Li L
    Cell Stem Cell; 2018 Sep; 23(3):355-369.e9. PubMed ID: 30146412
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epigenetically Aberrant Stroma in MDS Propagates Disease via Wnt/β-Catenin Activation.
    Bhagat TD; Chen S; Bartenstein M; Barlowe AT; Von Ahrens D; Choudhary GS; Tivnan P; Amin E; Marcondes AM; Sanders MA; Hoogenboezem RM; Kambhampati S; Ramachandra N; Mantzaris I; Sukrithan V; Laurence R; Lopez R; Bhagat P; Giricz O; Sohal D; Wickrema A; Yeung C; Gritsman K; Aplan P; Hochedlinger K; Yu Y; Pradhan K; Zhang J; Greally JM; Mukherjee S; Pellagatti A; Boultwood J; Will B; Steidl U; Raaijmakers MHGP; Deeg HJ; Kharas MG; Verma A
    Cancer Res; 2017 Sep; 77(18):4846-4857. PubMed ID: 28684528
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disease-related potential of mutations in transcriptional cofactors CREB-binding protein and p300 in leukemias.
    Shigeno K; Yoshida H; Pan L; Luo JM; Fujisawa S; Naito K; Nakamura S; Shinjo K; Takeshita A; Ohno R; Ohnishi K
    Cancer Lett; 2004 Sep; 213(1):11-20. PubMed ID: 15312679
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.